Potential role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) in the staging of primitive and recurrent medullary thyroid carcinoma

Journal of Endocrinological Investigation

Volumn 20, Issue 9, 1997, Pages 527-530

  Gasparoni, P ^a,b   Rubello, D ^a   Ferlin, G ^a  

^a Ospedale di Castelfranco Vto (TV)   (Italy)

^b Medicina Generate   (Italy)

Author keywords

Fluorine 18 deoxyglucose (FDG); Medullary thyroid carcinoma; Positron emission tomography (PET)

Indexed keywords

CALCITONIN; FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TUMOR MARKER;

ADULT; AGED; ARTICLE; CALCITONIN BLOOD LEVEL; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ERROR; FEMALE; HUMAN; LAPAROTOMY; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; RECURRENT CANCER; SCINTIGRAPHY; THYROID MEDULLARY CARCINOMA; ULTRASOUND;

EID: 0031440206     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03348014     Document Type: Article

References (20)

1. Brunt L.M., Wells S. Advances in the diagnosis and treatment of medullary thyroid carcinoma. Surg. Clin. North. Am. 67: 263, 1987.
2. Mazzaferri E.L. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Sem. Oncol. 14:315, 1988.
3. DeGroot L.J., Kaplan E.L., McCormik M., Strauss F. Natural history, treatment, and course of papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 71: 414, 1990.
4. Kallinowskii F., Buhr H.J., Meybier H., Eberhardt M., Herforth C. Medullary carcinoma of the thyroid - therapeutic strategy derived from fifteen years of experience. Surgery 774:491, 1993.
5. DeBesi P., Busnardo B., Toso S., Girelli M.E., Simioni N., Casara D., Zorat P.L., Fiorentino M.L. BAP (Bleomycin, Doxorubicin and Cisplatin) regimen in advanced thyroid carcinoma. J. Endocrinol. Invest. 14:475, 1991.
6. Nguyen T.D., Chessard J.L., Lagarde P., Cutuli B., Le Fur R., Reme-Saumon M., Prevost B., Panis X., Verrelle P., Chaplin G. Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of the Cancer Institutes. The radiotherapy cooperative group. Radioth. Oncol. 23: 1, 1992.
7. Guerra U., Pizzocaro C., Terzi A., Giubbini R., Bestagno M. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC). J. Nucl. Med. Allied Sci. 32:242, 1988.
8. Ugur O., Kostakoglu L., Guler N., Coner B., Uysal U., Elahi N., Haliliglu M., Yuksal D., Aras T., Bayhen H., Bekdik C. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Eur. J. Nucl. Med. 23: 1367, 1996.
9. Lebouthillier G., Morais J., Picard M., Picard D., Chartrand R., D'Amom P. Tc99m-sestamibi and other agents in the detection of medullary carcinoma of the thyroid. Clin. Nucl. Med. 18:657, 1993.
10. Baudin E., Lumbroso J., Schlumberger M., Leclere J., Giammorile F., Gardet P., Roche A., Travagli J.P., Parmenter C. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J. Nucl. Med. 32:912, 1996.
11. Manil L., Boudet F., Matte P., Gardet P., Saccavini J.C., Lumbroso J.D., Schlumberger M., Caillou B., Bazin J.P., Ricard M., Bellet D., Bohnon C., Tubiana M., Di Paola R., Parmentier C. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma. Cancer Res. 49: 548, 1989.
12. Zanin D.E.A., van Dongen A., Hoefnagel C.A., Bruning P.F. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and Thallium-201 scintigraphy in medullary thyroid carcinoma, a case report. J. Nucl. Med. 31: 1854, 1990.
13. Endo K., Shiomi K., Kasagi K. Imaging of the medullary thyroid cancer with 1311-MIBG. Lancet 2: 233, 1984.
14. Abdel-Dayen H.M., Scott A.M., Mecapiulac H.A., El-Gazzar A.A..H., Larson S.M. Role of 201TI chloride and 99mTc-sestamibi in tu-mor imaging. In: Freeman L.M. (Ed.), Nuclear Medicine Annual. Raven Press, New York, 1994, p. 181.
15. Casara D., Saladini G., Rubello D., Borsato N., Ferlin G. Scintigraphic localization of recurrrent medullary and differentiated thyroid carcinoma with 99mTc-MIBI. J. Nucl. Biol. Med. 38:166, 1994.
16. Goldemberg D.M. Monoclonal antibodies in cancer detection and therapy. Am. J. Med. 94: 297, 1993.
17. Juweid M., Sharkey R.M., Behr T. Improved detection of medullary thyroid cancer with radiolabeled monoclonal antibodies to carcinoembryonic antigen. J. Clin. Oncol. 14: 1209, 1996.
18. Strauss L.G., Conti P.S. The application of PET in clinical oncology. J. Nucl. Med. 32: 623, 1991.
19. Gupta N.C., Maloof J., Gunel E. Probability of malignancy in solitary pulmonary nodules using Fluorine-18-FDG. J. Nucl. Med. 37: 943, 1996.
20. Feine U., Lietzemmayer R., Hanke J.P., Held J., Wohrle H., Muller-Schauenburg W. Fuorine-1 8-FDG and iodine-131 Iodine uptake in thyroid cancer. J. Nucl. Med. 37: 1472, 1996.